Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) shot up 0.9% on Friday . The stock traded as high as $48.96 and last traded at $48.96. 332 shares changed hands during mid-day trading, a decline of 82% from the average session volume of 1,871 shares. The stock had previously closed at $48.50.
Hikma Pharmaceuticals Stock Up 0.9%
The company has a 50-day moving average price of $47.36 and a two-hundred day moving average price of $51.48.
Hikma Pharmaceuticals Cuts Dividend
The company also recently announced a dividend, which was paid on Monday, September 29th. Shareholders of record on Tuesday, August 19th were issued a dividend of $0.70 per share. This represents a yield of 340.0%. The ex-dividend date of this dividend was Monday, August 18th. Hikma Pharmaceuticals’s dividend payout ratio (DPR) is currently 10.34%.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
See Also
- Five stocks we like better than Hikma Pharmaceuticals
- What is a Bond Market Holiday? How to Invest and Trade
- Amazon Earnings: 3 Catalysts That Could Drive Shares to $300
- What is the Australian Securities Exchange (ASX)
- Why Chipotle Stock May Bounce After a Brutal Sell-Off
- EV Stocks and How to Profit from Them
- Why VGT May Be a Smarter Bet Than Chasing Individual Tech Stocks
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
